Cargando…
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
Acute myeloid leukemia (AML) is a devastating cancer affecting the hematopoietic system. Previous research has relied on RNA sequencing and microarray techniques to study the downstream effects of genomic alterations. While these studies have proven efficacious, they fail to capture the changes that...
Autores principales: | Caplan, Mika, Wittorf, Karli J., Weber, Kasidy K., Swenson, Samantha A., Gilbreath, Tyler J., Willow Hynes-Smith, R., Amador, Catalina, Hyde, R. Katherine, Buckley, Shannon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061297/ https://www.ncbi.nlm.nih.gov/pubmed/35177813 http://dx.doi.org/10.1038/s41375-022-01518-z |
Ejemplares similares
-
Loss of FBXO9 Enhances Proteasome Activity and Promotes Aggressiveness in Acute Myeloid Leukemia
por: Hynes-Smith, R. Willow, et al.
Publicado: (2019) -
FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia
por: Dobish, Kasidy K., et al.
Publicado: (2023) -
MONET: Multi-omic module discovery by omic selection
por: Rappoport, Nimrod, et al.
Publicado: (2020) -
The omics discovery REST interface
por: Dass, Gaurhari, et al.
Publicado: (2020) -
IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells
por: Liss, Franziska, et al.
Publicado: (2021)